PreventionGenetics Receives FDA Approval for its Companion Diagnostic Genetic Test as a Class II Medical Device
Developed in collaboration with Rhythm Pharmaceuticals, the test is the first FDA-authorized Class II molecular companion diagnostic device MARSHFIELD, Wis., June 30, 2022 /PRNewswire/ — PreventionGenetics, a subsidiary of Exact Sciences Corp., announced today that it was recently granted marketing authorization for the POMC/PCSK1/LEPR companion diagnostic (CDx) genetic test as a Class II device by … Read more